Legend Biotech CorporationLEGNNASDAQ
Loading
R&D Expense Growth Under PressureDecelerating
Percentile Rank29
3Y CAGR-38.3%
5Y CAGR-45.3%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-38.3%/yr
Annual compound
5Y CAGR
-45.3%/yr
Recent acceleration
Percentile
P29
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| 2024 | 8.20% |
| 2023 | 13.87% |
| 2022 | 7.12% |
| 2021 | 34.97% |
| 2020 | 43.36% |
| 2019 | 167.07% |
| 2018 | 639.93% |
| 2017 | 0.00% |